132 related articles for article (PubMed ID: 35842773)
1. Novel targets to overcome antiangiogenesis therapy resistance in glioblastoma multiforme: Systems biology approach and suggestion of therapy by galunisertib.
Hadizadeh M; AminJafari A; Parvizpour S; Ghasemi S
Cell Biol Int; 2022 Oct; 46(10):1649-1660. PubMed ID: 35842773
[TBL] [Abstract][Full Text] [Related]
2. Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release.
Di Vito C; Navone SE; Marfia G; Abdel Hadi L; Mancuso ME; Pecci A; Crisà FM; Berno V; Rampini P; Campanella R; Riboni L
Platelets; 2017 Sep; 28(6):585-594. PubMed ID: 27897101
[TBL] [Abstract][Full Text] [Related]
3. Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI.
Cho HR; Kumari N; Thi Vu H; Kim H; Park CK; Choi SH
Sci Rep; 2019 Jul; 9(1):11085. PubMed ID: 31366997
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
5. Identification of Hub Genes and Key Pathways Associated with Anti-
Arya KR; Bharath Chand RP; Abhinand CS; Nair AS; Oommen OV; Sudhakaran PR
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803224
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of VEGF in the treatment of glioblastoma.
Robles Irizarry L; Hambardzumyan D; Nakano I; Gladson CL; Ahluwalia MS
Expert Opin Ther Targets; 2012 Oct; 16(10):973-84. PubMed ID: 22876981
[TBL] [Abstract][Full Text] [Related]
7. ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.
Cam M; Charan M; Welker AM; Dravid P; Studebaker AW; Leonard JR; Pierson CR; Nakano I; Beattie CE; Hwang EI; Kambhampati M; Nazarian J; Finlay JL; Cam H
Neuro Oncol; 2020 Mar; 22(3):345-356. PubMed ID: 31763674
[TBL] [Abstract][Full Text] [Related]
8. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.
Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW
Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087
[TBL] [Abstract][Full Text] [Related]
9. Role of Ang1 and its interaction with VEGF-A in astrocytomas.
Zadeh G; Koushan K; Pillo L; Shannon P; Guha A
J Neuropathol Exp Neurol; 2004 Sep; 63(9):978-89. PubMed ID: 15453096
[TBL] [Abstract][Full Text] [Related]
10. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
Chang HH; Cheng YC; Tsai WC; Chen Y
Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
[TBL] [Abstract][Full Text] [Related]
11. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
Qin Y; Takahashi M; Sheets K; Soto H; Tsui J; Pelargos P; Antonios JP; Kasahara N; Yang I; Prins RM; Braun J; Gordon LK; Wadehra M
J Neurooncol; 2017 Aug; 134(1):29-40. PubMed ID: 28597184
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma.
Lu KV; Bergers G
CNS Oncol; 2013 Jan; 2(1):49-65. PubMed ID: 23750318
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.
Soda Y; Myskiw C; Rommel A; Verma IM
J Mol Med (Berl); 2013 Apr; 91(4):439-48. PubMed ID: 23512266
[TBL] [Abstract][Full Text] [Related]
14. Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration.
Bazan NG; Reid MM; Flores VAC; Gallo JE; Lewis W; Belayev L
Cancer Metastasis Rev; 2021 Sep; 40(3):643-647. PubMed ID: 34519960
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic therapies in the management of glioblastoma.
Schulte JD; Aghi MK; Taylor JW
Chin Clin Oncol; 2021 Aug; 10(4):37. PubMed ID: 32389001
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis.
Sonoda Y; Kanamori M; Deen DF; Cheng SY; Berger MS; Pieper RO
Cancer Res; 2003 Apr; 63(8):1962-8. PubMed ID: 12702589
[TBL] [Abstract][Full Text] [Related]
17. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
Park JH; Kim MJ; Kim WJ; Kwon KD; Ha KT; Choi BT; Lee SY; Shin HK
Cancer Lett; 2020 May; 478():71-81. PubMed ID: 32173479
[TBL] [Abstract][Full Text] [Related]
18. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
[TBL] [Abstract][Full Text] [Related]
19. The Hippo-TAZ axis mediates vascular endothelial growth factor C in glioblastoma-derived exosomes to promote angiogenesis.
Wang Z; Yuan Y; Ji X; Xiao X; Li Z; Yi X; Zhu Y; Guo T; Wang Y; Chen L; Liu Y
Cancer Lett; 2021 Aug; 513():1-13. PubMed ID: 34010715
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of vascular smooth muscle cells in glioblastoma multiforme.
Takeuchi H; Hashimoto N; Kitai R; Kubota T; Kikuta K
J Neurosurg; 2010 Aug; 113(2):218-24. PubMed ID: 19929197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]